Progress in blood pressure control in autosomal dominant polycystic kidney disease. 2000

T Ecder, and C L Edelstein, and G M Fick-Brosnahan, and A M Johnson, and I T Duley, and P A Gabow, and R W Schrier
Department of Medicine, Division of Renal Diseases and Hypertension, University of Colorado School of Medicine, Denver, CO, USA.

Hypertension occurs commonly in autosomal dominant polycystic kidney disease (ADPKD) and is an important factor in the progression of the disease and cardiovascular mortality. The aim of this prospective 15-year study is to report the rate of blood pressure control and the potential effect of a 10-point education program developed by our center for ADPKD patients and their physicians. The patients' blood pressure treatment was managed by their primary care physicians. Three 5-year periods were analyzed in which similar rates of hypertension in patients with ADPKD were present (63% to 68%). In the first period (1985 to 1989), the rate of blood pressure control (<140/90 mm Hg) was 38% for 216 hypertensive patients with ADPKD. From 1990 to 1994, the percentage of blood pressure control increased to 55% in 194 hypertensive patients with ADPKD (P < 0.001 versus 1985 to 1989); and the level of blood pressure control increased to 64% in 181 hypertensive patients with ADPKD during 1995 to 1999 (P < 0.001 versus 1985 to 1989). Although this percentage of blood pressure control in patients with ADPKD remains suboptimal, it compares very favorably with the 27% estimated blood pressure control in patients with essential hypertension from 1991 to 1994 in the United States.

UI MeSH Term Description Entries
D006977 Hypertension, Renal Persistent high BLOOD PRESSURE due to KIDNEY DISEASES, such as those involving the renal parenchyma, the renal vasculature, or tumors that secrete RENIN. Hypertensions, Renal,Renal Hypertension,Renal Hypertensions
D008297 Male Males
D010353 Patient Education as Topic The teaching or training of patients concerning their own health needs. Education of Patients,Education, Patient,Patient Education
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D016891 Polycystic Kidney, Autosomal Dominant Kidney disorders with autosomal dominant inheritance and characterized by multiple CYSTS in both KIDNEYS with progressive deterioration of renal function. Autosomal Dominant Polycystic Kidney,Kidney, Polycystic, Autosomal Dominant,ADPKD,Adult Polycystic Kidney Disease,Adult Polycystic Kidney Disease Type 1,Adult Polycystic Kidney Disease Type 2,Polycystic Kidney Disease 2,Polycystic Kidney Disease, Adult,Polycystic Kidney Disease, Adult Type 2,Polycystic Kidney Disease, Adult, Type II,Polycystic Kidney Disease, Autosomal Dominant,Polycystic Kidney Disease, Type 2,Polycystic Kidney, Type 1 Autosomal Dominant Disease,Polycystic Kidney, Type 2 Autosomal Dominant Disease

Related Publications

T Ecder, and C L Edelstein, and G M Fick-Brosnahan, and A M Johnson, and I T Duley, and P A Gabow, and R W Schrier
December 2014, The New England journal of medicine,
T Ecder, and C L Edelstein, and G M Fick-Brosnahan, and A M Johnson, and I T Duley, and P A Gabow, and R W Schrier
March 2015, The New England journal of medicine,
T Ecder, and C L Edelstein, and G M Fick-Brosnahan, and A M Johnson, and I T Duley, and P A Gabow, and R W Schrier
March 2015, The New England journal of medicine,
T Ecder, and C L Edelstein, and G M Fick-Brosnahan, and A M Johnson, and I T Duley, and P A Gabow, and R W Schrier
March 2015, The New England journal of medicine,
T Ecder, and C L Edelstein, and G M Fick-Brosnahan, and A M Johnson, and I T Duley, and P A Gabow, and R W Schrier
March 2015, The New England journal of medicine,
T Ecder, and C L Edelstein, and G M Fick-Brosnahan, and A M Johnson, and I T Duley, and P A Gabow, and R W Schrier
October 2019, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences,
T Ecder, and C L Edelstein, and G M Fick-Brosnahan, and A M Johnson, and I T Duley, and P A Gabow, and R W Schrier
November 2017, JAMA internal medicine,
T Ecder, and C L Edelstein, and G M Fick-Brosnahan, and A M Johnson, and I T Duley, and P A Gabow, and R W Schrier
October 1997, Pediatric nephrology (Berlin, Germany),
T Ecder, and C L Edelstein, and G M Fick-Brosnahan, and A M Johnson, and I T Duley, and P A Gabow, and R W Schrier
January 2014, Kidney & blood pressure research,
T Ecder, and C L Edelstein, and G M Fick-Brosnahan, and A M Johnson, and I T Duley, and P A Gabow, and R W Schrier
November 2017, JAMA internal medicine,
Copied contents to your clipboard!